Researchers examined data on more than 3,400 BP devices used all over the world. A significant majority of them were never clinically validated for accuracy.
Weight gain during early training causes cardiovascular problems for collegiate football players.
Philips is the first big name to sign on as a sponsor of Cardio Ex, a heart-themed medical video game targeted at interventional cardiologists, Medical Design & Outsourcing reported Oct. 21.
A smartphone app introduced at the 45th Argentine Congress of Cardiology (SAC 2019) this week in Buenos Aires improved heart patients’ adherence to their drug regimen after a CV event.
Pregnant women may soon be able to assess their own risk of preeclampsia, according to work published in the Journal of Engineering and Science in Medical Diagnostics and Therapy.
A novel machine learning algorithm improved patient selection for CRT in a study of nearly 1,000 heart failure patients, representing an opportunity to optimize care and spare certain individuals from a pricey procedure that might not benefit them.
Pharmaceutical company AstraZeneca announced Oct. 21 that its drug Farxiga—or dapagliflozin—was approved by the FDA to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes.
Short-term opioid prescriptions could have long-term consequences for heart patients with cardiac implantable electronic devices, according to work published in Heart Rhythm Oct. 21.
The Bristol-Myers Squibb-Pfizer Alliance and Fitbit on Oct. 17 announced they’d be partnering to improve timely diagnosis of atrial fibrillation in people at an increased risk of stroke.
